Wanbury Limited (BOM:524212)
India · Delayed Price · Currency is INR 331.20
-1.30 (-0.39%)
At close: Jul 27, 2026
Wanbury Market Cap
Wanbury has a market cap or net worth of 11.56 billion as of July 27, 2026. Its market cap has increased by 44.07% in one year.
Market Cap
11.56B
Enterprise Value
13.72B
Revenue
6.50B
Ranking
n/a
PE Ratio
16.99
Stock Price
331.20
ChartMarket Cap Chart
Since February 7, 2005, Wanbury's market cap has increased from 1.77B to 11.56B, an increase of 553.71%. That is a compound annual growth rate of 9.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 11.56B | 45.81% |
| Dec 31, 2025 | 7.93B | -17.28% |
| Dec 31, 2024 | 9.58B | 121.65% |
| Dec 29, 2023 | 4.32B | 169.44% |
| Dec 30, 2022 | 1.60B | -40.72% |
| Dec 31, 2021 | 2.71B | 135.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TTK Healthcare | 14.82B |
| Fredun Pharmaceuticals | 14.80B |
| Amrutanjan Health Care | 14.76B |
| Shukra Pharmaceuticals | 13.94B |
| Fermenta Biotech | 12.40B |
| Syncom Formulations (India) | 12.31B |
| Lincoln Pharmaceuticals | 11.66B |
| Sudarshan Pharma Industries | 10.06B |